These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease. Li L; Chen H; Shi J; Chai S; Yan L; Meng D; Cai Z; Guan J; Xin Y; Zhang X; Sun W; Lu X; He M; Li Q; Yan X J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38834048 [TBL] [Abstract][Full Text] [Related]
5. Breathomics in the setting of asthma and chronic obstructive pulmonary disease. Bos LD; Sterk PJ; Fowler SJ J Allergy Clin Immunol; 2016 Oct; 138(4):970-976. PubMed ID: 27590400 [TBL] [Abstract][Full Text] [Related]
6. Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis. Rufo JC; Madureira J; Fernandes EO; Moreira A Allergy; 2016 Feb; 71(2):175-88. PubMed ID: 26476125 [TBL] [Abstract][Full Text] [Related]
13. New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS. Malik M; Demetrowitsch T; Schwarz K; Kunze T Commun Biol; 2024 Mar; 7(1):258. PubMed ID: 38431745 [TBL] [Abstract][Full Text] [Related]
14. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239 [TBL] [Abstract][Full Text] [Related]
15. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach. Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990 [TBL] [Abstract][Full Text] [Related]
16. Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project. Ahmed WM; Brinkman P; Weda H; Knobel HH; Xu Y; Nijsen TM; Goodacre R; Rattray N; Vink TJ; Santonico M; Pennazza G; Montuschi P; Sterk PJ; Fowler SJ J Breath Res; 2018 Oct; 13(1):016001. PubMed ID: 30272570 [TBL] [Abstract][Full Text] [Related]
17. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Dallinga JW; Robroeks CM; van Berkel JJ; Moonen EJ; Godschalk RW; Jöbsis Q; Dompeling E; Wouters EF; van Schooten FJ Clin Exp Allergy; 2010 Jan; 40(1):68-76. PubMed ID: 19793086 [TBL] [Abstract][Full Text] [Related]
18. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711 [TBL] [Abstract][Full Text] [Related]
19. Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. Caldeira M; Perestrelo R; Barros AS; Bilelo MJ; Morête A; Câmara JS; Rocha SM J Chromatogr A; 2012 Sep; 1254():87-97. PubMed ID: 22835687 [TBL] [Abstract][Full Text] [Related]
20. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]